<DOC>
	<DOCNO>NCT00518921</DOCNO>
	<brief_summary>This multi-center multi-national , randomize , double blind , placebo-controlled , 28-day treatment study BAY 68-4986 take orally matching placebo .</brief_summary>
	<brief_title>Capadenoson Angina Pectoris</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>The primary diagnosis chronic stable angina mildmoderate intensity define Canadian Cardiovascular Society Functional Class IIIII , presence definitive coronary artery disease . Male female subject age 35 75 year ( female , postmenopausal permanently sterilize ) Stable angina mildmoderate intensity ( Canadian class IIIII ) antianginal medication change last 5 week Inability withdraw current antianginal therapy Inability withdraw concomitant therapy would interfere interpretation study result</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>adenosin agonist</keyword>
	<keyword>chronic stable angina</keyword>
</DOC>